Call 800 665 0411 to learn about our services for your stock

Search   Follow Investorideas on Twitter   Investorideas is on Facebook   Investorideas is on Youtube   Investorideas is on Pinterest  Investorideas is on stocktwits   Investorideas is on tumblr   Investorideas is on LinkedIn   Investorideas Instagram   Investorideas Telegram   Investorideas Gettr   Investorideas RSS

Share on StockTwits

Congress Approves Spending Bill Protecting Medical Marijuana States from Federal Interference

Legislation renews spending restrictions that prevent federal law enforcement from targeting medical marijuana patients and businesses in compliance with state law


WASHINGTON - March 23, 2018 ( Newswire) A spending bill passed by Congress early Friday contains language that renews restrictions on the use of federal funds to interfere with state medical marijuana programs. If approved by the president, the legislation will continue to prevent the Department of Justice from spending resources to target medical marijuana patients and providers who are in compliance with state law. These protections are set to expire on September 30 and would need to be renewed in the FY2019 spending bill. This language was originally approved in 2014 and has been included in every subsequent budget agreement.

On January 4, Attorney General Jeff Sessions rescinded a Department of Justice policy instituted in 2013 that directed federal prosecutors not to enforce federal marijuana laws against individuals and businesses that are in compliance with state medical or adult-use marijuana laws. This move created uncertainty in states where marijuana is legal for adults, but passage of the spending bill ensures that medical marijuana programs will still be protected for the remainder of the fiscal year.

"Patients across the country will be relieved to hear that Congress has maintained the current policy of allowing states to make their own decisions on medical marijuana policy," said Matthew Schweich, executive director for the Marijuana Policy Project. "A strong majority of American voters oppose federal interference in state-level marijuana laws. Any actions by the federal government against medical marijuana patients or their providers would represent a dangerous and unjust backwards step on public health. Lawmakers are increasingly recognizing the benefits of medical marijuana, as well as the role it can play in our efforts to combat a nationwide opioid crisis that tragically claimed the lives of tens of thousands of Americans last year."

Recent studies suggest that marijuana may be used to treat opiate addiction as well as many of the conditions for which opiates are commonly prescribed. Several states where marijuana is legal for medical purposes have shown links between reforming their marijuana laws and positive opiate-related public health outcomes.

"It is imperative that Congress continue to include these temporary protections in the federal budget until comprehensive marijuana policy reforms are passed," Schweich continued.

Twenty-nine states, the District of Columbia, and the U.S. territories of Guam and Puerto Rico have enacted effective medical marijuana laws. Marijuana is legal and regulated for adults in eight states, and adult possession and limited home cultivation are legal in Vermont and the District of Columbia.

The Marijuana Policy Project is the nation's largest marijuana policy organization. For more information, visit

Marijuana / Hemp Stocks

Marijuana / Hemp Stocks

At and

Like Marijuana / Hemp Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

Also check out our AI blog Global Cannabis Investing - features Investor Ideas Cannabis news

More Info: Newswire

This news is published on the Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: Learn more about publishing your news release and our other news services on the newswire

Global investors must adhere to regulations of each country. Please read privacy policy:

That's all it takes to get an article published on Investor Ideas - Learn More